Oxford Uni scientists study Siga’s Tpoxx for protection against monkeypox
August 24, 2022Research and Development
The team at Oxford University, who conducted the landmark RECOVERY trial of COVID-19 therapies, is now studying if Siga Technologies’ …
Paediatric Investigation Plan approved by MHRA
August 24, 2022Research and Development
Northwest Biotherapeutics has announced the approval from the MHRA of the company’s Paediatric Investigation Plan (PIP). The development, regulatory review, …
Togo becomes first country to eliminate four neglected tropical diseases
August 24, 2022Research and Development
WHO has announced that the Republic of Togo has been confirmed as the first country to eliminate four devastating neglected …
Open Orphan signs £10.4 million contract with global pharma client
August 23, 2022Manufacturing and Production
Open Orphan has announced that its subsidiary hVIVO has signed a £10.4 million contract with an unnamed major global pharmaceutical …
UK to offer mini dose of monkeypox jab amid low stocks
August 23, 2022Manufacturing and Production
Three NHS sites will begin a pilot offering eligible patients smaller doses of monkeypox vaccine, following global shortages of the …
Initiative to improve next generation cancer diagnostics
August 23, 2022Manufacturing and Production
The Medical Device Innovation Consortium (MDIC) has formally launched its Somatic Reference Samples (SRS) Initiative with a pilot project, aiming …
Dengue vaccine approved in Indonesia regardless of prior exposure
August 23, 2022Manufacturing and Production
Takeda have announced the dengue vaccine, QDENGA®, was approved by the Indonesia National Agency for Drug and Food Control. Dengue …
Approval of only twice-yearly HIV treatment option
August 22, 2022Sales and Marketing
The European Commission (EC) has granted a Marketing Authorisation for Sunlenca (lenacapavir) injection and tablets for the treatment of HIV …
NICE issues positive appraisal document for combination treatment for advanced kidney cancer
August 22, 2022Sales and Marketing
NICE has published an appraisal consultation document (ACD) recommending the use of lenvatinib as a therapeutic option for untreated intermediate …
EMA accept marketing authorisation application for invasive candidiasis treatment
August 22, 2022Sales and Marketing
The EMA has accepted the marketing authorisation application (MAA) for rezafungin, for the treatment of invasive candidiasis in adult patients. …
New WHO recommendations for Ebola treatments and improved access
August 22, 2022Sales and Marketing
WHO has published its first guideline for Ebola virus disease therapeutics, calling on the global community to increase access to …
GSK awarded UNICEF contract for malaria vaccine
August 19, 2022Medical Communications
In 2020, nearly half a million children died from malaria in Africa alone, a rate of one child death per …
New COVID-19 study from The Lancet Psychiatry journal shows higher risk of brain fog
August 19, 2022Medical Communications
The study also found that adults faced an increased risk of anxiety and depression, but this subsided within two months …
Home-based brain stimulation study on stroke survivors finds mixed results
August 19, 2022Medical Communications
26 stroke survivors were given four weeks of remotely supervised transcranial direct current stimulation (RS-tDCS) in an at-home cognitive rehabilitation …
Jazz Pharmaceuticals takes groundbreaking epilepsy drug Epidiolex for adolescents into phase III trial
August 19, 2022Medical Communications
The phase III trials will assess Epidiolex over 14 weeks in a randomised, double-blind, placebo-controlled study, enrolling paediatric patients aged …
GSK’s new drug application for momelotinib accepted by FDA
August 18, 2022Business Services
The potential drug treatment is for myelofibrosis patients with anaemia UK-based GSK has announced that the US Food and Drug …
NHS Scotland recommends Chiesi’s Trimbow for asthma
August 18, 2022Business Services
In the UK, 5.4 million people are currently receiving treatment for asthma Chiesi Limited has announced that the Scottish Medicines …
Newly discovered peptide shows promising results in preventing seizures; a potential future treatment for epilepsy and Alzheimer’s
August 18, 2022Business Services
A study published in The American Society for Clinical Investigation highlights developments made by researchers to develop A1R-CT, a peptide …
New method involving musical tests can enable early detection of cognitive decline
August 18, 2022Business Services
Researchers at Tel Aviv University have created a method which uses musical tests and a portable brain activity-measuring device to …
Evonetix commences access programme for synthesised DNA
August 17, 2022Research and Development
Researchers are invited to apply to receive DNA that has been synthesised using Evonetix’s platform Evonetix has announced the opening …
